Nephrology Flashcards
Contrast-induced nephropathy
- definition
- common interventions
- prevention
- drug to hold to avoid
25% increase in creatinine occurring 2 -5 days after administration.
Common interventions: CT, angiography, PCI
Prevention
the evidence base currently supports the use of intravenous 0.9% sodium chloride at a rate of 1 mL/kg/hour for 12 hours pre- and post- procedure. There is also evidence to support the use of isotonic sodium bicarbonate
high-risk for contrast-induced nephropathy should have metformin withheld for a minimum of 48 hours and until the renal function has been shown to be normal
acute interstitial nephritis
- causes
- common drugs causing
- symptoms and signs
- diagnosis
- management
Acute interstitial nephritis (AIN) typically arises following drug therapy in the majority of cases (~75%), with infections and systemic vasculitides (SLE, sarcoidosis) forming the rest
Common drugs - NSAIDs, penicillins, allopurinol, PPIs, ciprofloxacin
Signs - Sterile pyuria and white cell casts in the setting of rash and fever and joint pain
Diagnosis - renal biopsy
Management - stop drug, steroids, dialysis
Common nephrotoxic drugs
NSAIDs, aminoglycosides (amikacin, gentamicin) ACE inhibitors, angiotensin II receptor antagonists [ARBs] and diuretics
Definition of AKI
a rise in serum creatinine of 26 micromol/litre or greater within 48 hours
a 50% or greater rise in serum creatinine known or presumed to have occurred within the past 7 days
a fall in urine output to less than 0.5 ml/kg/hour for more than 6 hours in adults and more than
Drugs that may have to be stopped in AKI as increased risk of toxicity (but doesn’t usually worsen AKI itself)
Metformin
Digoxin
Lithium
Should be stopped in AKI as may worsen renal function
NSAIDs
High dose aspirin 300mg (the cardio protective 75mg dose is safe to continue)
Aminoglycosides (amik, gent)
• ACE inhibitors
• Angiotensin II receptor antagonists
• Diuretics
Indications for dialysis
Acidosis
Excess - hyperkalaemia
O- pulmonary oedema
Ureaemia (e.g. pericarditis, encephalopathy)
prevent the formation of ascites in patients with chronic liver disease
- Aldosterone antagonists such as spironolactone
- Loop diuretics
Prostate cancer management
T1/2
- watchful wait
- radical prostatectomy (side effect - erectile dysfunction)
- external beam radiotherapy/ brachytherapy (risk of proctitis, increased risk bladder colon cancer)
T3/t4 metastic prostate cancer
- we need to reduce androgen levels
- given GnRH agonists (eg. Zoladex Goserelin) paradoxically decrease LH levels overtime by causing increase overstimulation that disrupts the negative feedback mechanism
- to counteract the initial increase in LH which results in crease in testosterone and tumour flare (pain) we give anti-androgen eg. bicalutamide, cyproterone acetate
Or androgen synthesis inhibitor eg. abiraterone
- severe cases may benefit from bilateral orchidectomy
Renal transplant HLA matching - which is most important
DR is the most important
relative importance of the HLA antigens are as follows DR > B > A
Post kidney transplant problems
ATN of graft
vascular thrombosis
urine leakage
UTI
Renal transplantation rejection types
Hyperacute rejection (minutes to hours)
- due to pre-existing antibodies against ABO or HLA antigens
- a type II hypersensitivity reaction
- leads to widespread thrombosis of graft vessels → ischaemia and necrosis of the transplanted organ
- no treatment is possible and the graft must be removed
Acute graft failure (< 6 months)
- due to mismatched HLA —> Cell-mediated (cytotoxic T cells)
- asymptomatic and is picked up by a rising creatinine, pyuria and proteinuria
- other causes include cytomegalovirus infection
- may be reversible with steroids and immunosuppressants
Causes of chronic graft failure (> 6 months)
- both antibody and cell-mediated mechanisms —> fibrosis to the transplanted kidney (chronic allograft nephropathy)
- recurrence of original renal disease (MCGN > IgA > FSGS)
Henoch-Schonlein purpura (HSP)
- causes
- symptoms / signs
- treatment
- prognosis
IgA mediated vasculitis
Children - triggered by infection
Symptoms: palpable purpuric rash over buttocks, backs of limbs, localised oedema, haematuria, arthralgia
Treatment: supportive
Prognosis- one third get relapse, majority return to normal renal function
Diabetes insipidus
Inability to produce (cranial) or respond (nephrogenic) to anti diuretic hormone (vasopressin)
Cranial DI causes
- idiopathic
- pituitary gland surgery
- infiltration: sarcoidosis, haemochromarosis
- tumour
- head injury
Nephrogenic causes
- lithium
- genetic mutations in the ADH receptor
- tubulo-interstitial disease: obstruction, sickle-cell, pyelonephritis
- hypercalcaemia, hypokalaemia
Features - polyuria, polydipsia
Investigation - water deprivation test, plasma:urine osmolality (high urine osmolality automatically excludes)
Management
nephrogenic diabetes insipidus
- thiazides
- low salt/protein diet
central diabetes insipidus can be treated with desmopressin (Vasopressin receptor 2 agonist)
Autosomal dominant polystic kidney disease
ADPKD type 1 ADPKD type 2
85% of cases 15% of cases
Chromosome 16 Chromosome 4
renal failure earlier
Diagnostics: ultrasound
two cysts, unilateral or bilateral, if aged < 30 years
two cysts in both kidneys if aged 30-59 years
four cysts in both kidneys if aged > 60 years
Management: if already developed CKD - tolvaptan (vasopressin receptor 2 antagonist) which also slows cyst development
Most common cause of nephrotic syndrome in children
Minimal change >80%
Minimal change disease
- causes
- signs
- pathophysiology
- diagnosis by microscopy
- treatment
- prognosis
Causes nephrotic syndrome
Signs: peripheral oedema, hypoalbuminaemia, proteinuria
Causes: idiopathic (80-90%)
drugs: NSAIDs, rifampicin
Hodgkin’s lymphoma, thymoma
infectious mononucleosis
Pathophysiology - T cell and cytokine mediated —> effacement of foot processes and podocyte loss —> permeability of glomerular basement membrane
renal biopsy
normal glomeruli on light microscopy
electron microscopy shows fusion of podocytes and effacement of foot processes
Treatment
1. Oral steroids
2. Cyclophosphamide
Prognosis: thirds
1/3 have one episode
1/3 have infrequent episodes
1/3 have frequent relapses which cease by adulthood
Causes of nephrogenic Diabetes insipidus
Genetic - mutation to ADH receptor
Electrolytes - hypoK, hyperCa
Lithium demeclocycline
Tubulo-interstitial disease - obstruction, sickle cell, pyelonephritis
most common histological pattern seen in lupus nephritis
diffuse proliferative glomerulonephritis
which chromosome is implicated in ADPKD
type 1 - chr 16
type 2 - chr 4
what clotting factor is lost in nephrotic/nephritic syndrome resulting in clot formation?
antithrombin III and plasminogen
normal anion gap
8-14
antibody for
Idiopathic membranous glomerulonephritis
anti-phospholipase A2 antibodies
stones produced by Proteus mirabilis bacteria in UTI
magnesium ammonium phosphate stones
staghorn calculi
Young female, hypertension and asymmetric kidneys
fibromuscular dysplasia
drug treatment for polycystic kidney disease
tolvaptan (vasopressin receptor 2 antagonist)
— to slow the progression of cyst development